Balhousie Care Group finance director scoops national award

May 8, 2018

Mike Reid, finance director of Balhousie Care Group, has been named Finance Director of the Year at the prestigious FDs' Excellence Awards.

Mike won the award in the category of private company with turnover of £20m+ for his work in helping turn around the Perth-based care home group.

Mike joined the company in 2014 and has helped transform Balhousie Care from a firm facing major challenges and losing money, to one which is a leader in its sector and turning a profit. In 2017 he oversaw a £49m refinancing of the business, now in its 25th year of operation and with 25 care homes across Scotland.

The FDs Excellence Awards were held this week at the Royal College of Physicians in London as part of the 2018 FD Surgery which brought together more than 250 entrepreneurial finance directors for a day of debate, learning and networking.

Balhousie Care Group's Chairman Tony Banks said:

"Balhousie Care Group's journey over the last three years - from a company facing challenges within a sector under major pressure, to where it is today - has been remarkable. The appointment of Mike in 2014 was integral to turning things around. He came with a strong financial pedigree but no previous experience in the care sector. That fresh, analytical eye proved crucial in helping us steer our ship back on course to be nationally recognised as a leading independent provider of care services in Scotland."FDs Excellence Award

The FDs Excellence Award is the latest in a line of national accolades for Balhousie Care Group. Operations Director Louise Barnett took the title of Operations Manager of the Year at the National Care Awards. Last week dementia nurse consultant Yvonne Manson was named as a finalist in the RCNI Nurse Awards,which celebrates excellence in nursing care U.K.-wide.

To find out more about the FDs Excellence Awards or Balhousie Care Group visit www.balhousiecare.co.uk

 

Add new comment

By submitting this form, you accept the Mollom privacy policy.